Literature DB >> 6785089

Conservative management of infantile pyloric stenosis by nasoduodenal feeding.

Y Yamashiro, H Mayama, K Yamamoto, M Sato, G Nawate.   

Abstract

Fifty cases of infantile plyoric stenosis were treated conservatively by transpyloric nasoduodenal tube feeding. The mean age on admission was 38.2 days. Transpyloric intubation was carried out in all patients and 45 (90%) with infantile pyloric stenosis were cured by nasuduodenal feeding. Among 5 (10%) requiring surgical intervention, abandonment of nasoduodenal feeding was the cause in only 3, and the parents chose an operation in the remaining 2 a few days after nasoduodenal feeding had been started. In non-surgically cured cases (45), mean body weights on admission and at discharge were 3,750 g and 5,177 g respectively; the duration of nasoduodenal feeding was 8 to 37 days (mean 17.2 days), mean weight gain during nasoduodenal feeding was 42.7 g/day and mean hospital stay was 39.7 days (38.0 days in 43 cases without any associated disorder). This experience suggests that nasoduodenal feeding in this report is a more effective treatment for infantile pyloric stenosis than any traditional medical treatment and it could be the preferred management in the small group of patients for whom an operation could carry a high risk, or whose parents refuse operation.

Entities:  

Mesh:

Year:  1981        PMID: 6785089     DOI: 10.1007/BF00441922

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

Review 1.  Secretin, cholecystokinin and newer gastrointestinal hormones (first of two parts).

Authors:  P L Rayford; T A Miller; J C Thompson
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

2.  CONGENITAL PYLORIC STENOSIS: A CONTROLLED EVALUATION OF MEDICAL TREATMENT UTILIZING METHYL-SCOPOLAMINE-NITRATE.

Authors:  G W MELLIN; T V SANTULLI; H S ALTMAN
Journal:  J Pediatr       Date:  1965-03       Impact factor: 4.406

3.  Pyloric stenosis: selective medical and surgical treatment. A survey of sixteen years' experience.

Authors:  N M JACOBY
Journal:  Lancet       Date:  1962-01-20       Impact factor: 79.321

4.  Hypertrophic pyloric stenosis in infancy treated with methyl scopolamine nitrate.

Authors:  B D CORNER
Journal:  Arch Dis Child       Date:  1955-08       Impact factor: 3.791

5.  [Medical treatment of congenital pyloric stenosis. A review of treatment in a central hospital].

Authors:  N B B0ggild-Madsen
Journal:  Ugeskr Laeger       Date:  1975-01-20

Review 6.  Induction of pyloric hypertrophy by pentagastrin. An animal model for infantile hypertrophic pyloric stenosis.

Authors:  J A Dodge; A A Karim
Journal:  Gut       Date:  1976-04       Impact factor: 23.059

7.  [Treatment of spastic, hypertrophic pyloric stenosis with methyl scopolamine nitrate].

Authors:  H L Eschenbacher; H Göbel
Journal:  Klin Padiatr       Date:  1972-09       Impact factor: 1.349

8.  Medical management of pyloric stenosis.

Authors:  L R Day
Journal:  JAMA       Date:  1969-02-03       Impact factor: 56.272

9.  A nasojejunal tube for infant feeding.

Authors:  J W Rhea; J O Kilby
Journal:  Pediatrics       Date:  1970-07       Impact factor: 7.124

10.  [Retrospective study of congenital hypertrophic pyloric stenosis and pylorospasm: Surgical vs. non-surgical treatment (author's transl)].

Authors:  K H Schäfer; G Bingel
Journal:  Monatsschr Kinderheilkd       Date:  1975-06
  10 in total
  1 in total

Review 1.  Interstitial cells of Cajal, the Maestro in health and disease.

Authors:  Randa-M Mostafa; Yasser M Moustafa; Hosam Hamdy
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.